Pharmaceutical merger
Akorn Enterprises, Inc., and Hi-Tech Pharmacal, Inc., will sell the rights and assets to three generic prescription eye medication and two general topical anesthetics to Watson Laboratories, Inc., to settle FTC...To view the full article, register now.
Already a subscriber? Click here to view full article